Identification of soluble biomarkers that associate with distinct manifestations of long COVID

Identification of soluble biomarkers that associate with distinct manifestations of long COVID

Long coronavirus disease (COVID) is a heterogeneous clinical condition of uncertain etiology triggered by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we used ultrasensitive approaches to profile the immune system and the plasma proteome in healthy convalescent individuals and individuals with long COVID, spanning geographically independent cohorts from Sweden and the United Kingdom. Symptomatic disease was n…

Long COVID, a comprehensive systematic scoping review

To find out what is known from literature about Long COVID until January 30, 2021. We undertook a four-step search with no language restriction. A prelimin

Myth: Long COVID is entirely different to ME

ME: Challenge the myths, champion the facts!   On World ME day 12 May 2025 we invite you to join us in debunking 6 of the myths about Myalgic Encephalopmyelitis (ME/CFS) Myth 6: Long COVID is …

A Crash Course in: long COVID

A Crash Course in: long COVID bowkerf 9 May 2025 10:00 11:00 Our series of morning lectures sharing science from across the Crick in a simple and accessible way continues.Our next lecture in the series is with Emma Wall, visiting scientist in the Worldwide Influenza Centre. Long COVID has affected up to 2% of the entire UK population in the last 5 years, but we still don’t fully understand this often debilitating new disease. While we now know …

Persistent Lung and Heart Inflammation Found in Majority of Long COVID Patients

The post Persistent Lung and Heart Inflammation Found in Majority of Long COVID Patients appeared first on European Medical Journal.